Takara Bio Inc. (4974.T)
JPY 791.0
(1.54%)
JPY 791.0
(1.54%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 123.2 Billion JPY | -4.64% |
| 2022 | 129.2 Billion JPY | 11.66% |
| 2021 | 115.71 Billion JPY | 28.93% |
| 2020 | 89.75 Billion JPY | 19.65% |
| 2019 | 75 Billion JPY | 5.59% |
| 2018 | 71.04 Billion JPY | 3.17% |
| 2017 | 68.85 Billion JPY | 2.55% |
| 2016 | 67.14 Billion JPY | 0.83% |
| 2015 | 66.59 Billion JPY | 0.25% |
| 2014 | 66.42 Billion JPY | 6.28% |
| 2013 | 62.5 Billion JPY | 33.98% |
| 2012 | 46.64 Billion JPY | 5.94% |
| 2011 | 44.03 Billion JPY | 3.38% |
| 2010 | 42.59 Billion JPY | -2.42% |
| 2009 | 43.65 Billion JPY | 1.24% |
| 2008 | 43.11 Billion JPY | -4.8% |
| 2007 | 45.28 Billion JPY | -0.55% |
| 2006 | 45.53 Billion JPY | 2.47% |
| 2005 | 44.44 Billion JPY | 18.75% |
| 2004 | 37.42 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 121.75 Billion JPY | -1.18% |
| 2023 Q1 | 120.66 Billion JPY | -6.61% |
| 2023 FY | 123.2 Billion JPY | -4.64% |
| 2023 Q3 | 123.08 Billion JPY | -0.16% |
| 2023 Q4 | 123.2 Billion JPY | 0.1% |
| 2023 Q2 | 123.28 Billion JPY | 2.17% |
| 2022 Q4 | 129.2 Billion JPY | 0.83% |
| 2022 Q2 | 120.02 Billion JPY | 7.66% |
| 2022 Q1 | 111.48 Billion JPY | -3.65% |
| 2022 FY | 129.2 Billion JPY | 11.66% |
| 2022 Q3 | 128.14 Billion JPY | 6.76% |
| 2021 Q1 | 99.65 Billion JPY | 11.04% |
| 2021 Q2 | 104.77 Billion JPY | 5.14% |
| 2021 Q3 | 106.11 Billion JPY | 1.28% |
| 2021 FY | 115.71 Billion JPY | 28.93% |
| 2021 Q4 | 115.71 Billion JPY | 9.04% |
| 2020 Q3 | 83.84 Billion JPY | 8.41% |
| 2020 Q2 | 77.34 Billion JPY | 5.1% |
| 2020 FY | 89.75 Billion JPY | 19.65% |
| 2020 Q1 | 73.59 Billion JPY | -1.89% |
| 2020 Q4 | 89.75 Billion JPY | 7.04% |
| 2019 Q4 | 75 Billion JPY | 4.42% |
| 2019 Q3 | 71.83 Billion JPY | 1.41% |
| 2019 FY | 75 Billion JPY | 5.59% |
| 2019 Q2 | 70.83 Billion JPY | -0.79% |
| 2019 Q1 | 71.4 Billion JPY | 0.51% |
| 2018 Q4 | 71.04 Billion JPY | 0.47% |
| 2018 Q3 | 70.7 Billion JPY | 2.95% |
| 2018 FY | 71.04 Billion JPY | 3.17% |
| 2018 Q2 | 68.67 Billion JPY | 1.53% |
| 2018 Q1 | 67.64 Billion JPY | -1.76% |
| 2017 Q3 | 66.75 Billion JPY | 2.05% |
| 2017 Q2 | 65.41 Billion JPY | -0.6% |
| 2017 Q1 | 65.81 Billion JPY | -1.98% |
| 2017 FY | 68.85 Billion JPY | 2.55% |
| 2017 Q4 | 68.85 Billion JPY | 3.14% |
| 2016 Q2 | 63.34 Billion JPY | -2.41% |
| 2016 Q3 | 64.67 Billion JPY | 2.1% |
| 2016 FY | 67.14 Billion JPY | 0.83% |
| 2016 Q1 | 64.9 Billion JPY | -2.53% |
| 2016 Q4 | 67.14 Billion JPY | 3.82% |
| 2015 Q3 | 65.9 Billion JPY | 0.02% |
| 2015 Q1 | 64.8 Billion JPY | -2.44% |
| 2015 FY | 66.59 Billion JPY | 0.25% |
| 2015 Q2 | 65.88 Billion JPY | 1.68% |
| 2015 Q4 | 66.59 Billion JPY | 1.04% |
| 2014 Q3 | 63.26 Billion JPY | -0.48% |
| 2014 Q2 | 63.56 Billion JPY | 2.24% |
| 2014 Q1 | 62.17 Billion JPY | -0.52% |
| 2014 Q4 | 66.42 Billion JPY | 5.0% |
| 2014 FY | 66.42 Billion JPY | 6.28% |
| 2013 FY | 62.5 Billion JPY | 33.98% |
| 2013 Q2 | 64.8 Billion JPY | 37.51% |
| 2013 Q1 | 47.12 Billion JPY | 1.02% |
| 2013 Q4 | 62.5 Billion JPY | 4.27% |
| 2013 Q3 | 59.94 Billion JPY | -7.5% |
| 2012 Q3 | 43.96 Billion JPY | 1.11% |
| 2012 Q1 | 44.06 Billion JPY | 0.07% |
| 2012 Q2 | 43.48 Billion JPY | -1.32% |
| 2012 Q4 | 46.64 Billion JPY | 6.1% |
| 2012 FY | 46.64 Billion JPY | 5.94% |
| 2011 Q3 | 42.52 Billion JPY | -0.33% |
| 2011 Q4 | 44.03 Billion JPY | 3.54% |
| 2011 Q1 | 42.42 Billion JPY | -0.4% |
| 2011 FY | 44.03 Billion JPY | 3.38% |
| 2011 Q2 | 42.66 Billion JPY | 0.57% |
| 2010 Q2 | 42.19 Billion JPY | -0.18% |
| 2010 Q4 | 42.59 Billion JPY | 1.78% |
| 2010 Q3 | 41.84 Billion JPY | -0.82% |
| 2010 Q1 | 42.26 Billion JPY | -3.17% |
| 2010 FY | 42.59 Billion JPY | -2.42% |
| 2009 Q3 | 42.39 Billion JPY | -0.35% |
| 2009 FY | 43.65 Billion JPY | 1.24% |
| 2009 Q4 | 43.65 Billion JPY | 2.96% |
| 2009 Q2 | 42.54 Billion JPY | 0.0% |
| 2008 Q4 | 43.11 Billion JPY | 0.0% |
| 2008 FY | 43.11 Billion JPY | -4.8% |
| 2007 FY | 45.28 Billion JPY | -0.55% |
| 2006 FY | 45.53 Billion JPY | 2.47% |
| 2005 FY | 44.44 Billion JPY | 18.75% |
| 2004 FY | 37.42 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 6.58 Billion JPY | -1769.798% |
| PRISM BioLab Co.,LTD | 1.21 Billion JPY | -10070.411% |
| GNI Group Ltd. | 62.39 Billion JPY | -97.465% |
| Linical Co., Ltd. | 18.53 Billion JPY | -564.55% |
| Trans Genic Inc. | 9.81 Billion JPY | -1155.805% |
| MEDINET Co., Ltd. | 5.63 Billion JPY | -2086.791% |
| Soiken Holdings Inc. | 6.94 Billion JPY | -1673.749% |
| Cytori Cell Research Institute, Inc. | 5.81 Billion JPY | -2018.293% |
| AnGes, Inc. | 28.89 Billion JPY | -326.432% |
| OncoTherapy Science, Inc. | 867.27 Million JPY | -14106.221% |
| Nxera Pharma Co., Ltd. | 157.19 Billion JPY | 21.623% |
| Immuno-Biological Laboratories Co., Ltd. | 1.61 Billion JPY | -7512.033% |
| NanoCarrier Co., Ltd. | 5.07 Billion JPY | -2329.505% |
| Carna Biosciences, Inc. | 4.34 Billion JPY | -2732.416% |
| CanBas Co., Ltd. | 2.43 Billion JPY | -4964.297% |
| D. Western Therapeutics Institute, Inc. | 2.37 Billion JPY | -5091.224% |
| RaQualia Pharma Inc. | 6.93 Billion JPY | -1677.808% |
| Chiome Bioscience Inc. | 1.75 Billion JPY | -6934.555% |
| Kidswell Bio Corporation | 5.08 Billion JPY | -2322.688% |
| PeptiDream Inc. | 67.12 Billion JPY | -83.544% |
| Oncolys BioPharma Inc. | 2.04 Billion JPY | -5937.789% |
| Ribomic Inc. | 3.54 Billion JPY | -3373.303% |
| SanBio Company Limited | 5.04 Billion JPY | -2341.052% |
| Healios K.K. | 15.15 Billion JPY | -712.979% |
| BrightPath Biotherapeutics Co., Ltd. | 1.23 Billion JPY | -9914.737% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 3.01 Billion JPY | -3985.113% |
| Delta-Fly Pharma, Inc. | 1.47 Billion JPY | -8257.805% |
| StemRIM | 9.08 Billion JPY | -1256.905% |
| CellSource Co., Ltd. | 6.87 Billion JPY | -1690.868% |
| FunPep Company Limited | 2.49 Billion JPY | -4845.82% |
| Kringle Pharma, Inc. | 2.61 Billion JPY | -4604.969% |
| Stella Pharma Corporation | 3.82 Billion JPY | -3124.789% |
| TMS Co., Ltd. | 3.55 Billion JPY | -3365.978% |
| Noile-Immune Biotech Inc. | 5.77 Billion JPY | -2031.998% |
| Cuorips Inc. | 6.18 Billion JPY | -1892.113% |
| K Pharma,Inc. | 3.31 Billion JPY | -3617.883% |
| ReproCELL Incorporated | 9.05 Billion JPY | -1261.008% |
| PhoenixBio Co., Ltd. | 2.71 Billion JPY | -4437.476% |
| StemCell Institute Inc. | 6.54 Billion JPY | -1783.014% |
| Japan Tissue Engineering Co., Ltd. | 6.98 Billion JPY | -1662.927% |
| CellSeed Inc. | 2.46 Billion JPY | -4896.699% |